Riskpilot← Back to searchSign inGet full accessLYSAKER SPESIALISTKLINIKK AS
ASActiveOrg 918553150Lysaker Torg 5, 1366 LysakerMedical specialists activities · NACE 8622Est. 20176 employees
Revenue 2024
NOK 27,3M
+9% vs 2023
EBITDA margin
16.0%
-24% vs 2023
Equity ratio
4.3%
Financial strength
Net profit 2024
NOK 2,9M
-32% vs 2023
| Revenue | NOK 27,3M | +9% |
| EBITDA | NOK 4,4M | -24% |
| Net profit | NOK 2,9M | -32% |
| Total assets | NOK 10,5M | +25% |
| Equity | NOK 455K | -11% |
| Employees | 6 | — |
Legal name
LYSAKER SPESIALISTKLINIKK AS
Org number
918553150
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
22. februar 2017
Share capital
NOK 200 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Fremstilling og salg av tannlege-, lege- og spesialisttjenester, samt andre tjenester og produkter som naturlig faller inn under dette, herunder konsulent-, rådgivnings- og undervisningstjenester, samt eie og delta i andre virksomheter.
Address
Lysaker Torg 5, 1366 Lysaker
Phone
+4763796633
Email
romerike@spesialistklinikkene.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 8 914 | 10 378 | 20 818 | 25 031 | 27 284 |
| Staff expenses | −1 553 | −1 734 | −1 909 | −2 047 | −2 454 |
| EBITDA | −412 | 352 | 3 861 | 5 750 | 4 377 |
| Depreciation & amort. | −173 | −175 | −202 | −262 | −635 |
| EBIT | −585 | 177 | 3 659 | 5 488 | 3 742 |
| Net financials | −7 | 0 | −12 | −39 | −59 |
| Profit before tax | −592 | 178 | 3 646 | 5 448 | 3 683 |
| Tax | −127 | 37 | 802 | 1 200 | 808 |
| Net profit | −465 | 140 | 2 844 | 4 248 | 2 875 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 256 | 2 058 | 4 944 | 8 408 | 10 530 |
| Equity | 365 | 396 | 370 | 510 | 455 |
| Long-term debt | 7 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 884 | 1 662 | 4 574 | 7 898 | 10 075 |
| Total debt | 1 891 | 1 662 | 4 574 | 7 898 | 10 075 |
EBITDA margin
16.0%
This company
15.8%
Market median
+1% vs market
20202024
Equity ratio
4.3%
This company
38.2%
Market median
-89% vs market
20202024
Return on equity
631.6%
This company
18.4%
Market median
+3333% vs market
20202024
Net profit margin
10.5%
This company
8.1%
Market median
+30% vs market
20202024
Asset turnover
2.59×
This company
1.12×
Market median
+131% vs market
20202024
Debt / equity
22.13×
This company
0.62×
Market median
-3469% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
FM Chief Executive Officer | Chief Executive Officer | 2017 |
| Former (1) | ||
HK Deputy Member | Deputy Member | 2017 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Maqsood Holding As
LYSAKER SPESIALISTKLINIKK AS Board members of LYSAKER SPESIALISTKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Halima Khawaja Maqsood | Deputy Member | 0 companies |
| Farooq Maqsood | Chief Executive Officer | 0 companies |
| Stein Helge Glad Nordahl | Board of Directors | 0 companies |
| Kent Jensen | Chairman | 0 companies |